603233.SH
大参林
SSE · Healthcare · Biotechnology · CN
CNY 17.36
−1.70%Forward multiples
Based on analyst estimates
- P/E forward
- 14.60x
- P/E 2026E
- 14.42x
- P/E 2027E
- 12.44x
- P/E 2028E
- 11.02x
- P/S forward
- 0.67x
Trailing multiples
Trailing twelve months
- P/E TTM
- 16.01x
- PEG TTM
- 1.20x
- Price / book
- 2.77x
- Price / sales
- 0.78x
- Price / cash flow
- 4.70x
Enterprise value
- Enterprise value
- CNY 18.4B
- EV / sales
- 0.67x
- EV / EBITDA
- 7.70x
- EV / EBIT
- 9.61x
- Market cap
- CNY 19.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026